Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Surface Oncology, Inc. | 24,000 | reported | 08 Jun 2022 | tx 2+48,000 |
| HALOZYME THERAPEUTICS, INC. | 20,216 | reported | 01 Oct 2019 | tx 7+359,735−27,206 |
| BRISTOL MYERS SQUIBB CO | 11,429 | reported | 10 Mar 2026 | tx 20+108,307−37,663.39 |
| Mirati Therapeutics, Inc. | 0 | reported | 23 Jan 2024 | tx 33+243,616−184,700 |
| Mural Oncology plc | 0 | reported | 05 Dec 2025 | tx 7+40,582−32,120 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Mar 2026 | GRANT_AWARD | BRISTOL MYERS SQUIBB CO | 11,429 | 0.00 USD | deriv |
| 10 Mar 2026 | GRANT_AWARD | BRISTOL MYERS SQUIBB CO | 17,143 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | BRISTOL MYERS SQUIBB CO | 3,286 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | BRISTOL MYERS SQUIBB CO | 1,672 | 62.37 USD | |
| 27 Feb 2026 | EXERCISE | BRISTOL MYERS SQUIBB CO | 3,286 | 0.00 USD | deriv |
| 01 Feb 2026 | EXERCISE | BRISTOL MYERS SQUIBB CO | 10,079 | 0.00 USD | |
| 01 Feb 2026 | TAX_WITHHOLDING | BRISTOL MYERS SQUIBB CO | 3,810 | 55.05 USD | |
| 01 Feb 2026 | EXERCISE | BRISTOL MYERS SQUIBB CO | 10,079 | 0.00 USD | deriv |
| 05 Dec 2025 | OTHER | Mural Oncology plc | 15,021 | — | deriv |
| 05 Dec 2025 | OTHER | Mural Oncology plc | 8,637 | — | deriv |
| 05 Dec 2025 | OTHER | Mural Oncology plc | 8,462 | — | deriv |
| 11 Jun 2025 | GRANT_AWARD | Mural Oncology plc | 8,637 | 0.00 USD | deriv |
| 09 May 2025 | SALE | BRISTOL MYERS SQUIBB CO | 97.39 | 38.01 USD | anomaly |
| 10 Mar 2025 | GRANT_AWARD | BRISTOL MYERS SQUIBB CO | 20,084 | 0.00 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | BRISTOL MYERS SQUIBB CO | 13,389 | 0.00 USD | deriv |
| 01 Mar 2025 | TAX_WITHHOLDING | BRISTOL MYERS SQUIBB CO | 1,630 | 59.62 USD | |
| 01 Mar 2025 | EXERCISE | BRISTOL MYERS SQUIBB CO | 3,286 | 0.00 USD | |
| 01 Mar 2025 | EXERCISE | BRISTOL MYERS SQUIBB CO | 3,286 | 0.00 USD | deriv |
| 01 Feb 2025 | EXERCISE | BRISTOL MYERS SQUIBB CO | 10,078 | 0.00 USD | |
| 01 Feb 2025 | TAX_WITHHOLDING | BRISTOL MYERS SQUIBB CO | 3,725 | 58.95 USD | |
| 01 Feb 2025 | EXERCISE | BRISTOL MYERS SQUIBB CO | 10,078 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Mural Oncology plc | 8,462 | 3.35 USD | deriv |
| 10 Mar 2024 | GRANT_AWARD | BRISTOL MYERS SQUIBB CO | 3,870 | 0.00 USD | deriv |
| 10 Mar 2024 | GRANT_AWARD | BRISTOL MYERS SQUIBB CO | 5,805 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | BRISTOL MYERS SQUIBB CO | 9,858 | 0.00 USD | deriv |